With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh the rare risk of blood clots.
Tag: Blood Clots
J.&J. to Resume Its Covid Vaccine Rollout in Europe
The agency says the Johnson & Johnson coronavirus vaccine should have a warning for a potential risk for rare blood clots even though it believes the shot’s benefits outweigh risks. The agency did not recommend stopping use of the vaccine.
Handful of Unconfirmed Reports Are Being Examined After J.&J. Pause
Officials are trying to determine whether the reports might be cases of a rare, serious blood clotting disorder. It’s unclear whether the vaccine was responsible for the original cases.
Fauci Expects Decision on Using Johnson & Johnson Vaccine Friday
Dr. Anthony Fauci said that he expected experts meeting at the end of the week to recommend “some sort of either warning or restriction.”
‘We Were Flying Blind’: A Dr.’s Account of a Woman’s J.&J. Vaccine-Related Blood Clot Case
The disorder is rare, but so severe that the vaccine is on hold while experts weigh the risks and alert doctors and patients about symptoms and treatment.
Top health officials urge Americans to get vaccinated, but barely address the J. & J. pause.
Injections of the Johnson & Johnson coronavirus vaccine came to a sudden halt this week in the United States after a small number of rare blood clots emerged, though it is unclear if the shot was responsible.
Changing Strategy, E.U. Bets Big on Pfizer to Battle Covid
After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for a faster rollout of the Pfizer-BioNTech shot.
Once again, South Africa finds itself halting use, at least temporarily, of a Covid-19 vaccine it had bet on.
The change comes after concerns of rare blood clots that emerged in a handful of people in the United States who had received the shot.
Denmark says it’s permanently stopping use of the AstraZeneca vaccine.
The country hasn’t used it since last month, after concerns arose about a possible rare, dangerous side effect. Officials say they have adequate supplies of other vaccines to use instead.
A panel of independent experts to the C.D.C. says it needs more time to assess data and risks during the Johnson & Johnson vaccine pause.
The emergency meeting on Wednesday came after federal health authorities said they were studying rare blood clots in a small number of vaccine recipients and injections of the vaccine were halted across the country.